ALMR Alamar Biosciences, Inc.
ALMR Alamar Biosciences, Inc.
Healthcare · Medical Devices
Market read
POC $24.47 · VWAP $27.59 · +11.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
ALMR Price Structure
Loading timeframes…
Peers
Every watchlist ALMR belongs to, members best 30-day change first — ALMR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Alamar Biosciences furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 on August 11, 2026. Its 10-Q reports (GAAP): revenue $29M, diluted EPS -$0.22, net income -$13M.
full note →Against street estimates
How ALMR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about ALMR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 22
- ALMR: Alamar Biosciences Inc. Common Stock News (Oct 16 - Oct 22, 2026)
- ALMR News Today | Why did Alamar Biosciences stock go up today? $ALMR
- Alamar Biosciences News | Markets Insider
- Alamar Biosciences, Inc. (ALMR) Q2 FY2026 earnings call transcript
- ALAMAR BIOSCIENCES, INC. (ALMR)
- Alamar Biosciences Q2 2026 Earnings Results and Report
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ALMR research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.